SEC Form 3 · accession 0001104659-18-042360
Neon Therapeutics, Inc. · NTGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric S Lander
Director
Period of report
Jun 26, 2018
Accepted (ET)
Jun 26, 2018 · 8:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001694187
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 134,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $16.00 | holding | — | — | — | — | Jun 25, 2028 | Common Stock | 14,000 | — | D |
Explanation of responses
- F1This option shall vest in full on the earlier to occur of the first anniversary of the date of grant or the next annual meeting, subject to continued services as a member of the Board of Directors through such vesting date.
Remarks
Exhibit 24.1: Power of Attorney